T. Rowe Price Associates »

Cg Oncology shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $22M 591k 37.73
2024-06-30 $21M 665k 31.61
2024-03-31 $44M 992k 43.90

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
BlackRock
Braidwell
Vanguard Group
BlackRock
Avidity Partners Management
Henderson Group
RA Capital Management
Franklin Resources
Geode Capital Management
Alliancebernstein
BVF
State Street Corporation
Cormorant Asset Management

View all funds holding Cg Oncology